One of the most commonly detected abnormalities in human cancer is mut
ation of the p53 tumour suppressor gene. Intrinsic to the function of
p53 is its ability to induce apoptotic cell death and to cause cell cy
cle arrest. Moreover, p53 plays an important role in controlling the c
ellular response to DNA damaging agents such as ionizing radiation and
cancer chemotherapeutic drugs. Loss of p53 function causes increased
resistance to radiation and chemotherapeutic agents, and there is incr
easing evidence that p53 mutational status is an important determinant
of clinical outcome in cancer. This review will focus on recent data
describing the biochemistry of p53 function, its role in mediating apo
ptosis and cell cycle arrest and in the control of tumour growth and d
eath.